A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
NCT00475605
·
clinicaltrials.gov ↗
TERMINATED
Status
8071
Enrollment
INDUSTRY
Sponsor class
Stopped
Terminated early, endorsed by the FDA based on futility of continuation.
Conditions
Atopic Dermatitis
Sponsor
LEO Pharma